To consider & approve adoption of new set of Articles of Association of the Company, subject to the approval of the members of the Company.
Awaiting price reaction for this filing.
The board of Bijoy Hans Ltd, at a meeting on March 17, 2026, approved several major proposals that will go to shareholders via postal ballot. The company plans to change its name to Arvaya Healthcare Limited, suggesting a strategic shift toward the healthcare sector. It has raised its borrowing limit to Rs 200 crore and its loan/investment authorisation limit to Rs 200 crore, alongside a separate Rs 100 crore limit for transactions with interested persons. The board approved a more than threefold increase in authorised share capital, from Rs 60 crore (6 crore shares of Rs 10) to Rs 200 crore (20 crore shares of Rs 10), opening room for a large potential equity raise. Remuneration of the Managing Director and CFO was revised, and Mr. Salil Shetty was redesignated as Executive Director and CEO from April 1, 2026. A non-binding Letter of Intent was issued to GTT Data Solutions Limited for developing a technology platform for up to Rs 5 crore, payable in cash or equity.
Shareholders should watch the upcoming postal ballot closely, as the proposals together signal a potential pivot to healthcare, significantly higher debt and investment capacity, and a possible equity dilution given the sharply higher authorised share capital. The name change and leadership reshuffle suggest the company is repositioning itself, which could be positive if the new strategy delivers but also brings execution risk for retail investors.